Elsevier

Food and Chemical Toxicology

Volume 123, January 2019, Pages 42-49
Food and Chemical Toxicology

Review
Ginsenosides, catechins, quercetin and gut microbiota: Current evidence of challenging interactions

https://doi.org/10.1016/j.fct.2018.10.042 Get rights and content

Highlights

  • The daily intake of dietary supplements has been often recommended.

  • Gut microbiota contributes to the biotransformation of herbal products into active metabolites.

  • For ginsenosides, catechins and quercetin the metabolizing bacteria have been identified.

  • These active metabolites have been studied in vitro.

  • Further preclinical and clinical studies are necessary to confirm the potential beneficial effects of these metabolites.

Abstract

Recent studies have shown the role of gut microbiota in favoring the absorption of herbal products and the transformation of their active principles into metabolites endowed with biological activity. This review focuses on the evidence supporting the changes occurring, after metabolic reactions by specific bacteria that colonize the human gut, to ginseng-derived ginsenosides, green tea-derived catechins, and quercetin, this latter being a flavonoid aglycon bound to sugars and abundant in some vegetables and roots. Furthermore, the results of several studies demonstrating the potential beneficial effects of the active metabolites generated by these biotransformations on ginsenosides, catechins and quercetin will be reported.

Introduction

Over the last decades, several studies have focused on the cytoprotective effects of dietary supplements, thus raising the idea that a daily intake of these products improves the quality of life (Aiello et al., 2016; Corbi et al., 2016). According to the current regulation, herbal products (e.g., crude or commercial preparations of herbs) are considered as dietary supplements (Brown, 2017). The beneficial effects of herbal products depend on the abundance of phytochemicals (e.g. polyphenols and terpenes) with complex mechanisms of cytoprotection, including both the free radical-scavenging activity and enhancement of the cell stress response (Bjørklund and Chirumbolo, 2017; Davinelli et al., 2016; Mancuso, 2015; Hun Lee et al., 2013). However, the variable bioavailability of some phytochemicals, mainly polyphenols, has complicated the ability of randomized clinical trials to evaluate the therapeutic effects of these compounds in many diseases, thus preventing the accumulation of unambiguous evidence on their utility in humans (Mancuso et al., 2015, 2012; Lewandowska et al., 2013).

Quite recently, some papers have appeared in the scientific literature on the role played by the gut microbiota in favoring the beneficial effects of herbal products (Xu et al., 2017; Chen et al., 2016a). According to these studies, intestinal microbiota exerts effects at the pharmacokinetic and/or pharmacodynamic levels. By producing glycosidases and other enzymes catalyzing phase I reactions (e.g., oxygenation or hydrolysis), gut bacteria transform phytochemicals, very often bound to sugar moieties, into smaller molecules easily absorbed or in metabolites endowed with pharmacological effects (Espin et al., 2017; Xu et al., 2017). Although clinical studies unequivocally demonstrate the formation of these metabolites, their activity, in terms of modulation of specific cytoprotective targets, is essentially supported by in vitro studies.

Ginseng-derived ginsenosides and green tea-derived catechins have been taken as an example to discuss the multifaceted role of gut microbiota on herb-derived phytochemicals. One of the reasons why we have focused on these herbs, is that they are widely used, not only in the East, but also in the West and their beneficial effects have been extensively advertised. In addition, we have decided to describe the effects of gut microbiota on the flavonoid aglycon quercetin, which exists in nature bound to several sugars (see below) and is very abundant in roots and vegetables (e.g., lettuce, onions, etc.). Another reason that has led us to pick these phytochemicals is the fact that the bacteria involved in their intestinal biotransformation have been clearly identified and fully characterized, as well as the final metabolites formed through these activities. Undoubtedly, in making this choice we had to avoid diffusing general information on the chemical and pharmacological properties of ginsenosides, catechins and quercetin, for which we refer to extensive reviews available in the literature (e.g., Mancuso and Santangelo, 2017; Saeed et al., 2017; Anand David et al., 2016). Indeed, the goal of this review is to provide specific information about the changes performed by the gut microbiota on ginsenosides, catechins and quercetin and whether or not these modifications generate metabolites with biological effects.

Section snippets

Gut microbiota

In adults, the intestine is colonized by an extremely high number of bacteria, to the point that the intestinal microbiota is considered as a real organ, which performs digestive along with metabolic and endocrine functions (Goulet, 2015). The small intestine (duodenum, jejunum and ileum) contains a number of bacteria ranging from 104/ml content to 106-107/ml at the ileocecal junction, while the large intestine has a number of bacteria ranging between 1011 and 1012/g, most of which are

Ginsenosides

Ginseng is very popular in the Far East, in particular China and Korea, although ginseng-based products, such as some types of tonic beverages, are also highly diffused in the West (Baeg and So, 2013; Yun, 2001). The commercially available preparations of ginseng can be derived from several species of the Panax genus. Among these, the most widely used are raw preparations or extracts of P. ginseng, the Chinese or Korean species, and P. quinquefolius, considered the American species (Baeg and

Catechins

Tea is one of the most popular drinks in both the Eastern and Western countries. Two are the main types of teas consumed, black tea, which accounts for 60% of the whole product, and green tea accounting for 30% (Clifford et al., 2013). In both cases, the product originates from dried leaves of Camelia sinensis in non-fermented (green tea) or fermented (black tea) forms (Schantz et al., 2010). Green tea is rich in polyphenols (about 30% dry weight), among which the (˗)-epigallocatechin-3-O

Quercetin

Although quercetin is not an herbal product per se, it is the most common flavonoid present in many consumer foods, such as lettuce, red onion, radish leaves, cranberry and several others, and plants, including lovage, buckwheat, coriander and others more (Guo and Bruno, 2015; Formica and Regelson, 1995). Quercetin is found in nature conjugated to sugar moieties, such as rhamnose or rutinose, giving rise to the corresponding glycosides quercitrin and rutin (Guo and Bruno, 2015). The average

Conclusions

The first conclusion that can be drawn, by observing the evidence so far provided, is that the gut microflora becomes an important site for metabolic reactions by transforming ginsenosides, catechins and quercetin into active metabolites. This evidence supports the possibility that age-related or antibiotic-induced modifications of gut microflora, can cause important changes in terms of biotransformation of herbal products, thus affecting some of the expected beneficial effects. This is the

Conflicts of interest

The Authors have nothing to disclose.

Funding and sponsorship

This work was supported by Università Cattolica del Sacro Cuore grants “Fondi Ateneo” to C.M. and A.S.

References (117)

  • A.M. Dostal et al.

    Green tea extract and catechol-O-methyltransferase genotype modify fasting serum insulin and plasma Adiponectin concentrations in a randomized controlled trial of overweight and obese postmenopausal women

    J. Nutr.

    (2016 Jan)
  • J.C. Espín et al.

    The gut microbiota: a key factor in the therapeutic effects of (poly)phenols

    Biochem. Pharmacol.

    (2017 Sep 1)
  • J.V. Formica et al.

    Review of the biology of Quercetin and related bioflavonoids

    Food Chem. Toxicol.

    (1995 Dec)
  • L. Genton et al.

    Alterations of gut barrier and gut microbiota in food restriction, food deprivation and protein-energy wasting

    Clin. Nutr.

    (2015 Jun)
  • D.M. Goldberg et al.

    Absorption of three wine-related polyphenols in three different matrices by healthy subjects

    Clin. Biochem.

    (2003 Feb)
  • T. Grimm et al.

    Antioxidant activity and inhibition of matrix metalloproteinases by metabolites of maritime pine bark extract (pycnogenol)

    Free Radic. Biol. Med.

    (2004 Mar 15)
  • J. Gu et al.

    Compound K, a final intestinal metabolite of ginsenosides, enhances insulin secretion in MIN6 pancreatic β-cells by upregulation of GLUT2

    Fitoterapia

    (2013 Jun)
  • Y. Guo et al.

    Endogenous and exogenous mediators of quercetin bioavailability

    J. Nutr. Biochem.

    (2015 Mar)
  • J. Lee et al.

    Studies on absorption, distribution and metabolism of ginseng in humans after oral administration

    J. Ethnopharmacol.

    (2009 Feb 25)
  • C. Mancuso et al.

    Alzheimer's disease and gut microbiota modifications: the long way between preclinical studies and clinical evidence

    Pharmacol. Res.

    (2018 Mar)
  • C. Mancuso et al.

    Panax ginseng and Panax quinquefolius: from pharmacology to toxicology

    Food Chem. Toxicol.

    (2017 Sep)
  • C. Mancuso et al.

    Natural substances and Alzheimer's disease: from preclinical studies to evidence based medicine

    Biochim. Biophys. Acta

    (2012 May)
  • S. Park et al.

    Inhibition of JAK1/STAT3 signaling mediates compound K-induced apoptosis in human multiple myeloma U266 cells

    Food Chem. Toxicol.

    (2011 Jun)
  • M. Pfeuffer et al.

    Effect of quercetin on traits of the metabolic syndrome, endothelial function and inflammation in men with different APOE isoforms

    Nutr. Metabol. Cardiovasc. Dis.

    (2013 May)
  • M. Saeed et al.

    Green tea (Camellia sinensis) and l-theanine: medicinal values and beneficial applications in humans-A comprehensive review

    Biomed. Pharmacother.

    (2017 Nov)
  • H. Samavat et al.

    Effects of green tea catechin extract on serum lipids in postmenopausal women: a randomized, placebo-controlled clinical trial

    Am. J. Clin. Nutr.

    (2016 Dec)
  • J.P. Spencer

    Metabolism of tea flavonoids in the gastrointestinal tract

    J. Nutr.

    (2003 Oct)
  • A. Aiello et al.

    Nutrigerontology: a key for achieving successful ageing and longevity

    Immun. Ageing

    (2016 May 2)
  • A.V. Anand David et al.

    Overviews of biological importance of quercetin: a bioactive flavonoid

    Phcog. Rev.

    (2016 Jul-Dec)
  • I.C. Arts et al.

    The type of sugar moiety is a major determinant of the small intestinal uptake and subsequent biliary excretion of dietary quercetin glycosides

    Br. J. Nutr.

    (2004 Jun)
  • I.H. Baeg et al.

    The world ginseng market and the ginseng (Korea)

    J Ginseng Res

    (2013 Mar)
  • S.C. Bischoff

    Quercetin: potentials in the prevention and therapy of disease

    Curr. Opin. Clin. Nutr. Metab. Care

    (2008 Nov)
  • M. Blaut et al.

    Transformation of flavonoids by intestinal microorganisms

    Int. J. Vitam. Nutr. Res.

    (2003 Mar)
  • V. Brüll et al.

    Effects of a quercetin-rich onion skin extract on 24 h ambulatory blood pressure and endothelial function in overweight-to-obese patients with (pre-)hypertension: a randomised double-blinded placebo-controlled cross-over trial

    Br. J. Nutr.

    (2015 Oct 28)
  • L. Chen et al.

    Ginsenoside compound K sensitizes human colon cancer cells to TRAIL-induced apoptosis via autophagy-dependent and -independent DR5 upregulation

    Cell Death Dis.

    (2016)
  • M.K. Choo et al.

    A ginseng saponin metabolite suppresses tumor necrosis factor-alpha-promoted metastasis by suppressing nuclear factor-kappaB signaling in murine colon cancer cells

    Oncol. Rep.

    (2008 Mar)
  • W.S. Chung et al.

    Modulation of the human gut microbiota by dietary fibres occurs at the species level

    BMC Biol.

    (2016 Jan 11)
  • G. Corbi et al.

    Dietary phytochemicals in neuroimmunoaging: a new therapeutic possibility for humans?

    Front. Pharmacol.

    (2016 Oct 13)
  • A. Costabile et al.

    A double-blind, placebo-controlled, cross-over study to establish the bifidogenic effect of a very-long-chain inulin extracted from globe artichoke (Cynara scolymus) in healthy human subjects

    Br. J. Nutr.

    (2010 Oct)
  • L.A. David et al.

    Diet rapidly and reproducibly alters the human gut microbiome

    Nature

    (2014 Jan 23)
  • S. Davinelli et al.

    Dietary phytochemicals and neuro-inflammaging: from mechanistic insights to translational challenges

    Immun. Ageing

    (2016 Apr 14)
  • G.W. Dryden et al.

    A pilot study to evaluate the safety and efficacy of an oral dose of (-)-epigallocatechin-3-gallate-rich polyphenon E in patients with mild to moderate ulcerative colitis

    Inflamm. Bowel Dis.

    (2013 Aug)
  • S. Egert et al.

    Quercetin reduces systolic blood pressure and plasma oxidised low-density lipoprotein concentrations in overweight subjects with a high-cardiovascular disease risk phenotype: a double-blinded, placebo-controlled cross-over study

    Br. J. Nutr.

    (2009 Oct)
  • A. El Kaoutari et al.

    The abundance and variety of carbohydrate-active enzymes in the human gut microbiota

    Nat. Rev. Microbiol.

    (2013 Jul)
  • European Medicines Agency

    Assessment Report on Panax Ginseng C.A. Meyer, Radix

    (25 March 2014)
  • European Medicines Agency

    Assessment Report on Camellia Sinensis (L.) Kuntze, Non Fermentatum Folium

    (12 March 2013)
  • M. Fallani et al.

    Determinants of the human infant intestinal microbiota after the introduction of first complementary foods in infant samples from five European centres

    Microbiology

    (2011 May)
  • W. Fan et al.

    Impact of diet in shaping gut microbiota revealed by a comparative study in infants during the six months of life

    J. Microbiol. Biotechnol.

    (2014 Feb 28)
  • O. Goulet

    Potential role of the intestinal microbiota in programming health and disease

    Nutr. Rev.

    (2015 Aug)
  • E.U. Graefe et al.

    Pharmacokinetics and bioavailability of quercetin glycosides in humans

    J. Clin. Pharmacol.

    (2001 May)
  • Cited by (92)

    • A comprehensive review on bioavailability, safety and antidepressant potential of natural bioactive components from tea

      2022, Food Research International
      Citation Excerpt :

      Therefore, EGCG, GCG and EGCG3″Me exert their antidepressant function by modulating gut microbiota and producing potentially prebiotic-like SCFAs (Zhang et al. 2013). The catechins in oolong tea and green tea may have prebiotic-like activity, and can be used as functional food ingredients to prevent intestinal flora imbalance (Cheng et al. 2017; Cheng et al. 2018; Guo et al. 2019; Santangelo, Silvestrini, and Mancuso 2019), which show a potential therapeutic effect in regulating intestinal flora and become a dietary supplement for the treatment of depression. Tea active compounds indirectly regulate neurotransmitters by stimulating the gut microbiota to produce SCFAs, and can act on neurotransmitter pathways to exert antidepressant effects.

    View all citing articles on Scopus
    1

    These authors have equally contributed to this work.

    View full text